Next-generation anti-cancer therapy
February 2021
February 2021
Location: South Korea, Seoul
Investors 2
| Date | Name | Website |
| - | AJU IB Inv... | ajuib.co.k... |
| 20.06.2023 | Premier Pa... | premierpar... |
Mentions in press and media 2
| Date | Title | Description |
| 29.05.2024 | Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024 | SEOUL, South Korea and WASHINGTON, May 29, 2024 /PRNewswire/ -- Onconic Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for oncology and gastrointestinal disorders, announced today the ... |
| 25.04.2024 | Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD) | SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the tr... |